Drug Induced Steatohepatitis: An Uncommon Culprit of a Common Disease

@inproceedings{Rabinowich2015DrugIS,
  title={Drug Induced Steatohepatitis: An Uncommon Culprit of a Common Disease},
  author={Liane Rabinowich and Oren Shibolet},
  booktitle={BioMed research international},
  year={2015}
}
Nonalcoholic fatty liver disease (NAFLD) is a leading cause of liver disease in developed countries. Its frequency is increasing in the general population mostly due to the widespread occurrence of obesity and the metabolic syndrome. Although drugs and dietary supplements are viewed as a major cause of acute liver injury, drug induced steatosis and steatohepatitis are considered a rare form of drug induced liver injury (DILI). The complex mechanism leading to hepatic steatosis caused by… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS
9 Citations
147 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 147 references

End-stagemethotrexate-related liver disease is rare and associated with features of themetabolic syndrome

  • M. F. Dawwas andG.P. Aithal
  • Alimentary Pharmacology & Therapeutics, vol. 40…
  • 2014
Highly Influential
2 Excerpts

Similar Papers

Loading similar papers…